𝔖 Bobbio Scriptorium

✦ LIBER ✦

How symptomatic do depressed patients remain after benefiting from medication treatment?

✍ Scribed by Vito Agosti; Jonathan W. Stewart; Frederic M. Quitkin; Katja Ocepek-Welikson

Book ID: 115842286
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 481 KB
Volume: 34
Category: Article
ISSN: 1532-8384
DOI: 10.1016/0010-440x(93)90045-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

How are we doing with the treatment of e

How are we doing with the treatment of essential tremor (ET)? : Persistence of patients with ET on medication: data from 528 patients in three settings

✍ E. D. Louis; E. Rios; C. Henchcliffe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PCN110 HOW MUCH DO PATIENTS WITH RENAL C

PCN110 HOW MUCH DO PATIENTS WITH RENAL CELL CARCINOMA (RCC) VALUE PROGRESSION FREE SURVIVAL IN MEDICAL DECISION MAKING?–RESULTS FROM A BENEFIT-RISK CONJOINT STUDY

✍ AB Hauber; AF Mohamed; FR Johnson; MP Neary 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Reply from Authors re: Simon P. Kim, R.

Reply from Authors re: Simon P. Kim, R. Houston Thompson. Competing-Risks Analysis for Renal Cell Carcinoma: How Do We Accurately Communicate the Risks and Benefits of Treatment to Patients? Eur Urol 2011;60:1160–2

✍ Maxine Sun; Firas Abdollah; Marco Bianchi; Pierre I. Karakiewicz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Patients at high risk of progression aft

Patients at high risk of progression after radical prostatectomy: Do they all benefit from immediate post-operative irradiation? (EORTC trial 22911): Collette L, van Poppel H, Bolla M, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset J-F, Piérart M, European Organisation for Research and Treatment of Cancer (EORTC) Radiotherapy and Genito-urinary Groups, European Organisation for Research and Treatment of Cancer (EORTC) Data Center–Biostatistics, Brussels, Belgium

✍ Mark A. Ritter 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB